Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × semaglutide × Other × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Obesity 1

Interventions

tegaserod 1 semaglutide 1 penclomedine 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Thioctic Acid 1 Tablets 1 Radiation 1 Metformin 1 Megestrol Acetate 1 Low-Level Light Therapy 1 Lidocaine 1 Exercise 1 Exenatide 1 Diphenhydramine 1 Buspirone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2/3 Recruiting

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡